The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

Description

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

Ep439: Isabelle Kenyon Founder & CEO, Calibrate

In NYC, the Future of Healthtech Is Female

Marina Tarasova, Paloma Health, on modernizing thyroid care by The Pulse by Wharton Digital Health

How we're building the team and the tools to fight biology with biology, by Isabelle Kenyon

Claudia Jayne (@claudiajayne) / X

InnovationRx: #HealthcareIsHard; Plus Waning Covid Vaccine Immunity

These Are the Healthcare Startups Doing Layoffs in 2023

Prescription Weight Loss Drugs for Obesity Work—If Your Doctor Lets You Get Them - Bloomberg

August 2021 – The Health Care Blog

Isabelle Kenyon - Calibrate

$ 12.00USD
Score 4.6(134)
In stock
Continue to book